San Francisco California - Champaign Illinois - Illinois, U.S.A.
Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Hardware (& Manufacturing) • HealthTech (& Fitness) • Medical Devices (& Hospital Services) • Life Science
Tom Siegel serves as Managing Director and is a Co-Founder at Shepherd Ventures. He focuses on investments in technology, with particular emphasis on software and services, internet, digital media, mobile/wireless as well as food manufacturing and marketing. Past investments have resulted in many acquisitions and public offerings. Prior to Shepherd Ventures, Tom was a Senior Vice President with Advantage Capital Partners, a large early stage venture fund. He has also been a Managing Director of Illinois Ventures. Prior to Advantage Capital, Tom founded and/or served as President and Chief Executive Officer of various companies, primarily in the software, food, and publishing industries. Earlier in his career, Tom was a Management Consultant with, and a member of the M&A Group of KPMG. Tom received a BA in Economics and an MBA from the University of Illinois. He is a Certified Public Accountant (CPA) and also holds the designation of Chartered Financial Analyst (CFA). He is a member of the CFA Institute, is a past Chairman and President of the CFA Society San Diego and past board member of Software San Diego. The US Small Business Administration has selected him as a Financial Services Advocate of the Year. Tom has been an active investor, advisor, and/or board member for dozens of privately-held companies.
We're excited about companies that are leveraging fundamental changes in the world to create meaningful companies that improve people's lives. We want to back the most significant companies of tomorrow, and help them operate as conscious, win-for-all businesses.
Some of the fundamental changes we're intrigued by include:
- Robotics & automation
- Genetics & preventive health
- BrainTech & mental health
- Sustainability / renewable energy
- Mindfulness / consciousness
Not Interested In
We're not interested in ad tech or products that further the cycle of consumerism. We're not interested in entrepreneurs who don't value personal and leadership development.
Co-founder, @worklife . Previously, startup CEO coach and culture consultant. Founder, Wellsphere (acq. by IAC/Sequoia-backed HealthCentral), Unleashed.
Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Food & Beverage • Logistics (& Distribution) • Material Science • Medical Devices (& Hospital Services) • Aerospace (& Defense) • DeepTech • Healthcare (& Wellness) • Investment Management • Nanotechnology • Online Social
Vertical Venture Partners is a venture capital firm based in Palo Alto, California. The firm invests in companies operating in commercial products, transportation, retail, healthcare, education, energy, financial services, hospitality, real estate, telecommunication, transportation, aerospace, and defense sectors.
Investing in Software (Web Marketplace Saas..) &b... San Francisco (CA), U.S.A.
$201000000 (Series C)
$9400000 (Venture Round)
• Deep Genomics:
$180000000 (Series C)
• Deep Genomics:
$13000000 (Series A)
$9000000 (Funding Round)
$5200000 (Seed Round)
• Pendulum Therapeutics:
$54000000 (Series C)
• Pendulum Therapeutics:
$35000000 (Series B)
$7300000 (Seed Round)
$4700000 (Seed Round)
• Prime Roots:
$14000000 (Series A)
• Prime Roots:
$4300000 (Seed Round)
San Francisco (CA), U.S.A.
Software (Web Marketplace Saas..) • IT (& TMT) • Media • BioTech • Businesses Solutions • Hardware (& Manufacturing) • A.I. (& Big Data) • Web Security (& Privacy) • Analytics • Cloud Services (& Infrastructure) • Developer tools • Medical Devices (& Hospital Services)
Adam D'Augelli serves as Partner at True Ventures. Growing up, he was drawn to startups and technology - early on as a founder of a donation-based record label and a social business in India then later as a consultant to early-stage technology companies on the East Coast. Building upon this experience, he led the creation of "Digital Frontiers," a course at the University of Florida exploring how the Internet and Technology are changing the global business landscape. He graduated Magna Cum Laude from the University of Florida with a BS & MS in Finance. Adam D'Augelli serves as Board Member at Terramino Foods.
Valor Capital Group is a venture capital firm which is focused on US and Brazil cross-border opportunities with a local presence in New York, Silicon Valley and Brazil. It also provides growth equity investments. It invests in the cybersecurity, education, health and wellness, finance and logistics sectors. The firm was founded in 2011 and is headquartered in New York, New York.
Golden Seeds is an angel investor group and acts as an early-stage investment firm which specializes in seed, early stage and later stage investments. The firm focuses on women-led companies and invests in the B2B and B2C technology, healthcare and consumer products sectors. The firm was founded in 2005 and is headquartered in New York, New York.
Investing in Software (Web Marketplace Saas..) &b... Paris, France
• Oxxon Therapeutics:
$15000000 (Venture Round)
• Axial Therapeutics:
$37300000 (Series C)
• Abalos Therapeutics:
$31000000 (Series A)
$12000000 (Series A)
$92040000 (Later stage VC)
$50000000 (Later stage VC)
• Tibot Technologies:
$3300000 (Early stage VC)
Software (Web Marketplace Saas..) • Other • IT (& TMT) • BioTech • AgroTech • FinTech (& Financials services) • Hardware (& Manufacturing) • Energy • Retail (& E-Commerce) • CleanTech • HealthTech (& Fitness) • Food & Beverage • Material Science • Medical Devices (& Hospital Services) • DeepTech • Healthcare (& Wellness) • Life Science • Mobile • Consumer • Pharmaceutical (& Medicine) • Oncology
Seventure Partners is a venture capital firm that seek to invest in the hardware and telecommunication, information technology and life sciences sectors. The firm was founded in 1997 and is based in Paris, France.